Portfolio company
ALLEGRO
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops nanotechnology-based injectable hydrogel devices to treat osteoarthritis in human and veterinary patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Hy2Care
This company develops injectable hydrogel implants that facilitate natural cartilage repair for patients with joint injuries to prevent osteoarthritis.
TYBR Health
This company develops a hydrogel system for orthopaedic surgeons to protect tendons and ligaments from internal scarring following surgical procedures.
Hyalex Orthopaedics
This company develops synthetic cartilage and implant systems to restore damaged joint surfaces for patients with osteoarthritis or cartilage injuries.
Atro Medical
This company develops synthetic meniscus prostheses to restore knee function and relieve pain for patients with chronic knee injuries.
Gentis
This company developed an injectable biomaterial implant to restore biomechanical function in degenerated spinal discs for patients with spinal disc disease.
Allay Therapeutics
The company develops long-acting localized pain management technology for patients recovering from surgery.
NaNotics
This biopharmaceutical company develops subtractive nanoparticles that capture and clear pathogenic molecules from the blood to treat cancer and inflammatory diseases in humans and dogs.
AmacaThera
The company develops injectable hydrogel drug delivery platforms for pharmaceutical partners to provide sustained post-surgical pain management and localised therapeutic release.
